These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 30339939

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Matrix Metalloproteinase-2 Activity is Associated with Divergent Regulation of Calponin-1 in Conductance and Resistance Arteries in Hypertension-induced Early Vascular Dysfunction and Remodelling.
    Parente JM, Pereira CA, Oliveira-Paula GH, Tanus-Santos JE, Tostes RC, Castro MM.
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):246-256. PubMed ID: 28374979
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension.
    Pereira SC, Parente JM, Belo VA, Mendes AS, Gonzaga NA, do Vale GT, Ceron CS, Tanus-Santos JE, Tirapelli CR, Castro MM.
    Atherosclerosis; 2018 Mar; 270():146-153. PubMed ID: 29425960
    [Abstract] [Full Text] [Related]

  • 5. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.
    Castro MM, Rizzi E, Rodrigues GJ, Ceron CS, Bendhack LM, Gerlach RF, Tanus-Santos JE.
    Free Radic Biol Med; 2009 May 01; 46(9):1298-307. PubMed ID: 19248829
    [Abstract] [Full Text] [Related]

  • 6. TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure.
    Mattos BR, Bonacio GF, Vitorino TR, Garcia VT, Amaral JH, Dellalibera-Joviliano R, Franca SC, Tanus-Santos JE, Rizzi E.
    Biochem Pharmacol; 2020 Oct 01; 180():114121. PubMed ID: 32592722
    [Abstract] [Full Text] [Related]

  • 7. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
    Martinez ML, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):224-30. PubMed ID: 18634778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metalloproteinase-2 contributes to vascular dysfunction in early hypertension.
    Blascke de Mello MM, Neves VGO, Parente JM, Pernomian L, de Oliveira IS, Pedersoli CA, Awata WMC, Tirapelli CR, Arantes EC, Tostes RCA, Schulz R, Castro MM.
    Eur J Pharmacol; 2024 Nov 15; 983():176981. PubMed ID: 39241943
    [Abstract] [Full Text] [Related]

  • 11. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.
    Ceron CS, Rizzi E, Guimaraes DA, Martins-Oliveira A, Cau SB, Ramos J, Gerlach RF, Tanus-Santos JE.
    Matrix Biol; 2012 May 15; 31(4):261-70. PubMed ID: 22342460
    [Abstract] [Full Text] [Related]

  • 12. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension.
    Guimarães DA, Rizzi E, Ceron CS, Martins-Oliveira A, Gerlach RF, Shiva S, Tanus-Santos JE.
    Redox Biol; 2015 Dec 15; 6():386-395. PubMed ID: 26343345
    [Abstract] [Full Text] [Related]

  • 13. Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects.
    Rizzi E, Amaral JH, Guimarães DA, Conde-Tella SO, Pinheiro LC, Gerlach RF, Castro MM, Tanus-Santos JE.
    Free Radic Biol Med; 2019 Jan 15; 130():234-243. PubMed ID: 30399409
    [Abstract] [Full Text] [Related]

  • 14. The hydrogen sulfide donor 4-carboxyphenyl-isothiocyanate decreases blood pressure and promotes cardioprotective effect through reduction of oxidative stress and nuclear factor kappa B/matrix metalloproteinase (MMP)-2 axis in hypertension.
    Pernomian L, Blascke de Mello MM, Parente JM, Sanches-Lopes JM, Tanus-Santos JE, Parreiras E Silva LT, Antunes-Rodrigues J, da Conceição Dos Santos R, Elias LLK, Fabro AT, Silva CAA, Fazan R, de Castro MM.
    Life Sci; 2024 Aug 15; 351():122819. PubMed ID: 38857651
    [Abstract] [Full Text] [Related]

  • 15. Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension.
    Marçal DM, Rizzi E, Martins-Oliveira A, Ceron CS, Guimaraes DA, Gerlach RF, Tanus-Santos JE.
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan 15; 383(1):35-44. PubMed ID: 21058008
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinase-2 proteolysis of calponin-1 contributes to vascular hypocontractility in endotoxemic rats.
    Castro MM, Cena J, Cho WJ, Walsh MP, Schulz R.
    Arterioscler Thromb Vasc Biol; 2012 Mar 15; 32(3):662-8. PubMed ID: 22199370
    [Abstract] [Full Text] [Related]

  • 17. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.
    Ceron CS, Rizzi E, Guimarães DA, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE.
    Free Radic Biol Med; 2013 Dec 15; 65():47-56. PubMed ID: 23806385
    [Abstract] [Full Text] [Related]

  • 18. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability.
    Castro MM, Rizzi E, Ceron CS, Guimaraes DA, Rodrigues GJ, Bendhack LM, Gerlach RF, Tanus-Santos JE.
    Nitric Oxide; 2012 Mar 31; 26(3):162-8. PubMed ID: 22327038
    [Abstract] [Full Text] [Related]

  • 19. β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E, Guimaraes DA, Ceron CS, Prado CM, Pinheiro LC, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE.
    Free Radic Biol Med; 2014 Aug 31; 73():308-17. PubMed ID: 24933619
    [Abstract] [Full Text] [Related]

  • 20. Verapamil decreases calpain-1 and matrix metalloproteinase-2 activities and improves hypertension-induced hypertrophic cardiac remodeling in rats.
    Mendes AS, Blascke de Mello MM, Parente JM, Omoto ACM, Neto-Neves EM, Fazan R, Tanus-Santos JE, Castro MM.
    Life Sci; 2020 Mar 01; 244():117153. PubMed ID: 31830479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.